Omeprazole is a potent, highly specific, and clinically efficacious anti-secretory agent. Current clinical data suggest that omeprazole could be a useful drug in the short-term treatment of patients with severe erosive oesophagitis resistant to standard H2-receptor antagonist therapy. The magnitude of omeprazole's eventual role in the treatment of acid secretory-related disorders will depend on the results of its expanded postmarketing clinical experience and upon resolution of concerns regarding potential adverse effects associated with long-term administration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2036.1991.tb00750.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!